141 related articles for article (PubMed ID: 29749476)
1. miR‑23a suppresses pancreatic cancer cell progression by inhibiting PLK‑1 expression.
Chen B; Zhu A; Tian L; Xin Y; Liu X; Peng Y; Zhang J; Miao Y; Wei J
Mol Med Rep; 2018 Jul; 18(1):105-112. PubMed ID: 29749476
[TBL] [Abstract][Full Text] [Related]
2. Long non‑coding RNA ZEB2‑AS1 affects cell proliferation and apoptosis via the miR‑122‑5p/PLK1 axis in acute myeloid leukemia.
Guan J; Liu P; Wang A; Wang B
Int J Mol Med; 2020 Oct; 46(4):1490-1500. PubMed ID: 32700753
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation.
Zhang H; Zhang K; Xu Z; Chen Z; Wang Q; Wang C; Cui J
BMC Cancer; 2021 Feb; 21(1):163. PubMed ID: 33588776
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-195 Suppresses the Progression of Pancreatic Cancer by Targeting DCLK1.
Zhou B; Sun C; Hu X; Zhan H; Zou H; Feng Y; Qiu F; Zhang S; Wu L; Zhang B
Cell Physiol Biochem; 2017; 44(5):1867-1881. PubMed ID: 29224010
[TBL] [Abstract][Full Text] [Related]
5. The MicroRNA3686 Inhibits the Proliferation of Pancreas Carcinoma Cell Line by Targeting the Polo-Like Kinase 1.
Jin HY; Qiu XG; Yang B
Biomed Res Int; 2015; 2015():954870. PubMed ID: 26090465
[TBL] [Abstract][Full Text] [Related]
6. miR-301a promotes pancreatic cancer cell proliferation by directly inhibiting Bim expression.
Chen Z; Chen LY; Dai HY; Wang P; Gao S; Wang K
J Cell Biochem; 2012 Oct; 113(10):3229-35. PubMed ID: 22628193
[TBL] [Abstract][Full Text] [Related]
7. MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.
Zhou SL; Tang QL; Zhou SX; Ren RZ
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2084-2091. PubMed ID: 30915753
[TBL] [Abstract][Full Text] [Related]
8. Efficient inhibition of human colorectal carcinoma growth by RNA interference targeting polo-like kinase 1 in vitro and in vivo.
Xu WJ; Zhang S; Yang Y; Zhang N; Wang W; Liu SY; Tian HW; Dai L; Xie Q; Zhao X; Wei YQ; Deng HX
Cancer Biother Radiopharm; 2011 Aug; 26(4):427-36. PubMed ID: 21797676
[TBL] [Abstract][Full Text] [Related]
9. MiR-593-5p promotes the development of hypoxic-induced pulmonary hypertension via targeting PLK1.
Zhao TF; Wang SY; Zou XZ; Zhao HD
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3495-3502. PubMed ID: 31081105
[TBL] [Abstract][Full Text] [Related]
10. Polo-like kinase 1 contributes to the tumorigenicity of BEL-7402 hepatoma cells via regulation of Survivin expression.
He Z; Wu J; Dang H; Lin H; Zheng H; Zhong D
Cancer Lett; 2011 Apr; 303(2):92-8. PubMed ID: 21330050
[TBL] [Abstract][Full Text] [Related]
11. LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis.
Zhang H; Zhu C; He Z; Chen S; Li L; Sun C
J Exp Clin Cancer Res; 2020 Sep; 39(1):179. PubMed ID: 32891166
[TBL] [Abstract][Full Text] [Related]
12. hsa_circRNA_001587 upregulates SLC4A4 expression to inhibit migration, invasion, and angiogenesis of pancreatic cancer cells via binding to microRNA-223.
Zhang X; Tan P; Zhuang Y; Du L
Am J Physiol Gastrointest Liver Physiol; 2020 Dec; 319(6):G703-G717. PubMed ID: 32878470
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer.
Yu Y; Liu L; Ma R; Gong H; Xu P; Wang C
Tumour Biol; 2016 Oct; 37(10):14249-14257. PubMed ID: 27571739
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-139 inhibits pancreatic-cancer carcinogenesis by suppressing RalB via the Ral/RAC/PI3K pathway.
Wang Y; Zheng Y; Chen Q; Dai Y; Li T
Arch Biochem Biophys; 2021 Jun; 704():108719. PubMed ID: 33290747
[TBL] [Abstract][Full Text] [Related]
15. Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer.
Ito T; Sato F; Kan T; Cheng Y; David S; Agarwal R; Paun BC; Jin Z; Olaru AV; Hamilton JP; Selaru FM; Yang J; Matsumura N; Shimizu K; Abraham JM; Shimada Y; Mori Y; Meltzer SJ
Int J Cancer; 2011 Nov; 129(9):2134-46. PubMed ID: 21170987
[TBL] [Abstract][Full Text] [Related]
16. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.
Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C
Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-494 acts as a tumor suppressor in pancreatic cancer, inhibiting epithelial-mesenchymal transition, migration and invasion by binding to SDC1.
Yang Y; Tao X; Li CB; Wang CM
Int J Oncol; 2018 Sep; 53(3):1204-1214. PubMed ID: 29956739
[TBL] [Abstract][Full Text] [Related]
18. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA LINC00514 accelerates pancreatic cancer progression by acting as a ceRNA of miR-28-5p to upregulate Rap1b expression.
Han Q; Li J; Xiong J; Song Z
J Exp Clin Cancer Res; 2020 Aug; 39(1):151. PubMed ID: 32771045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]